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completely segregates with the ACHM phenotype within 
the family. The frameshift variant was absent in public vari-
ant databases, in 130 exomes from unrelated Pakistani indi-
viduals, and in 235 ethnically matched controls. The vari-
ant is predicted to result in a truncated protein that lacks the 
DNA binding and transmembrane domains and therefore 
affects the function of ATF6 as a transcription factor that 
initiates the unfolded protein response during endoplasmic 
reticulum (ER) stress. Immunolabeling with anti-ATF6 
antibodies showed localization throughout the mouse neu-
ronal retina, including retinal pigment epithelium, photore-
ceptor cells, inner nuclear layer, inner and outer plexiform 
layers, with a more prominent signal in retinal ganglion 
cells. In contrast to cytoplasmic expression of wild-type 
protein, in heterologous cells ATF6 protein with the 
p.Glu119Glyfs*8 variant is mainly confined to the nucleus. 
Our results imply that response to ER stress as mediated by 
the ATF6 pathway is essential for color vision in humans.
Introduction
Achromatopsia (ACHM) is an autosomal recessive hetero-
geneous disorder characterized by symptoms that include 
the inability to discriminate colors, reduced visual acuity 
primarily in daylight, nystagmus and severe photophobia 
(Michaelides et al. 2004). Initially, ACHM was consid-
ered as a stationary disorder but recent imaging studies 
have shown the progressive nature of disease in several 
patients (Thiadens et al. 2010; Aboshiha et al. 2014). Its 
prevalence is estimated to be about 1 in 30,000 individuals 
worldwide. To date, mutations in CNGA3 [MIM 600053], 
CNGB3 [MIM 605080], GNAT2 [MIM 139340], PDE6C 
[MIM 600827] and PDE6H [MIM 601190] are known to 
cause ACHM (Kohl et al. 1998, 2000, 2002, 2012; Chang 
Abstract Achromatopsia (ACHM) is an early-onset reti-
nal dystrophy characterized by photophobia, nystagmus, 
color blindness and severely reduced visual acuity. Cur-
rently mutations in five genes CNGA3, CNGB3, GNAT2, 
PDE6C and PDE6H have been implicated in ACHM. We 
performed homozygosity mapping and linkage analysis in 
a consanguineous Pakistani ACHM family and mapped the 
locus to a 15.12-Mb region on chromosome 1q23.1–q24.3 
with a maximum LOD score of 3.6. A DNA sample from 
an affected family member underwent exome sequenc-
ing. Within the ATF6 gene, a single-base insertion variant 
c.355_356dupG (p.Glu119Glyfs*8) was identified, which 
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et al. 2009). The proteins encoded by these genes are cone-
specific and have critical roles in the phototransduction 
cascade occurring in the cone photoreceptors. CNGA3 and 
CNGB3 mutations are the major cause of ACHM world-
wide, with mutations in GNAT2, PDE6C and PDE6H play-
ing a lesser role (Kohl et al. 2012). However, the known 
gene mutations do not account for all cases of ACHM 
(Saqib et al. 2011).
Using homozygosity mapping and linkage analysis, 
we mapped a new locus for ACHM in a consanguine-
ous Pakistani family. Within the mapped region, from 
exome sequence data we identified a frameshift variant 
c.355_356dupG (p.Glu119Glyfs*8) in the ATF6 [MIM 
605537] gene which encodes cyclic AMP-dependent acti-
vating transcription factor-6 alpha. The p.Glu119Glyfs*8 
variant affects the targeting of ATF6 protein in heterolo-
gous cells. Immunostaining revealed ubiquitous expres-
sion of ATF6 in the neuronal retina. Our results highlight 
the importance of the ATF6-mediated signaling pathway to 
color vision in humans.
Materials and methods
Subjects
This study was initiated after obtaining approval from the 
institutional review boards of Quaid-i-Azam University 
and Baylor College of Medicine and Affiliated Hospitals. 
Informed consent was obtained from all participating indi-
viduals. Blood samples were collected from four affected 
and seven healthy individuals (Fig. 1a) and genomic DNA 
was extracted with GenElute™ blood genomic DNA kit 
(Sigma-Aldrich, St. Louis, MO, USA). A detailed interview 
was conducted with family members to gather information 
on pedigree structure, comorbidities, onset of disease and 
initial symptoms. The clinical diagnosis was based on pre-
senting symptoms, physical examinations, visual acuity 
measurement, fundoscopy, color vision test and full-field 
electroretinography (ffERG).
Genotyping and linkage analysis
DNA samples from 11 family members underwent a 
genome-wide scan using the Infinium® HumanCoreEx-
ome BeadChip (Illumina, USA) which contains ~550 K 
single-nucleotide polymorphism (SNP) markers. The 
resulting genotype data were analyzed using PedCheck 
(O’Connell and Weeks 1998) to identify Mendelian incon-
sistences and MERLIN (Abecasis et al. 2002) to detect 
double recombination events, which occur within small 
physical distances that are most likely due to genotyp-
ing errors. Markers with suspected errors were removed 
from subsequent analyses. HomozygosityMapper (Seelow 
et al. 2009) was used to identify regions of homozygosity. 
Two-point and multipoint parametric linkage analyses 
were performed using Superlink (Silberstein et al. 2006) 
and MERLIN respectively, using a fully penetrant auto-
somal recessive mode of inheritance with no phenocopies 
and a disease allele frequency of 0.001. Allele frequen-
cies for SNP markers were estimated from the founders 
and reconstructed founders from 16 Pakistani families for 
whom genotype data were obtained using the same array. 
For multipoint linkage analysis, genetic map positions 
were obtained through interpolation from physical maps 
to the Rutgers combined linkage-physical map build 37 
(Matise et al. 2007).
Exome sequencing
Exome sequencing was performed using a DNA sample 
from affected individual III-1 (Fig. 1a). Sequence capture 
was performed with the Roche NimbleGen SeqCap EZ 
Human Exome Library v.2.0 to target 36.6 Mb of sequence. 
Sequencing was carried out on an Illumina HiSeq and fastq 
files were aligned to the human reference sequence (hg19) 
using Burrows–Wheeler Aligner (Li and Durbin 2009). 
Realignment of regions containing indels, recalibration of 
base qualities, and variant detection and calling were car-
ried out using the Genome Analysis Toolkit (McKenna 
et al. 2010). Annotation of variant sites was performed 
using SeattleSeq 137.
The exome data were analyzed to find within the region 
of homozygosity coding or splice variants which are not in 
dbSNP and had a minor allele frequency (MAF) <0.05 % 
in the Exome Aggregation Consortium (ExAC) data-
base which includes data from >60,000 next-generation 
sequences. Occurrence of the ATF6 c.355_356dupG variant 
was also examined using exomes from 130 unrelated Paki-
stani individuals who are affected with a Mendelian trait 
but do not have eye-related phenotypes.
Mutation analysis
Sanger sequencing was used to confirm the co-segrega-
tion of the c.355_356dupG variant in exon 5 of ATF6 
(NM_007348.3) with ACHM within the family using 
primers 5′GGAAGAAATGTAGCAACAGATCAA3′ and 
5′CCAGTGACAGGCTTATCTTCC3′. DNA samples 
from 235 Pakistani control individuals were also screened 
for the ATF6 variant. Amplified PCR products were puri-
fied by ExoSAP-IT (Affymetrix, Cleveland, OH, USA) and 
sequenced using BigDye Terminator v3.1 Cycle Sequenc-
ing Kit (Life Technologies, Carlsbad, CA, USA). Sequence 
data were analyzed with Sequencher 4.9 (Gene Codes Cor-
poration, Ann Arbor, MI, USA).
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Multiple ATF6 and ATF6-like protein sequences were 
derived by blastp from the UniProt database and aligned 
using Clustal Omega (Sievers et al. 2011). Molecular mod-
eling of wild-type and mutant ATF6 was performed using 
Phyre2 (Kelley and Sternberg 2009) with CREB protein 
structure as template (Protein Data Bank ID 1DH3).
cDNA synthesis and reverse transcription (RT)‑PCR
To check the expression of ATF6 in the eye, total RNA sam-
ples were obtained for human eye (Biochain Institute, New-
ark, CA, USA) and retinal pigment epithelial cells (ScienCell 
Research Laboratories, Carlsbad, CA, USA). cDNA was 
synthesized using 1 μg RNA, SMARTScribe Reverse Tran-
scriptase (Clontech, Mountain View, CA, USA) and random 
hexamers (Invitrogen, Carlslbad, CA, USA). Multiple primer 
sets (Table S1) were used to detect the expression of ATF6 iso-
forms in the RNA samples from human eye and retinal pig-
ment epithelium cells. GAPDH was used as internal control.
Western blot analysis
All animals used in this study were kept with the approval 
of the Institutional Animal Care and Use Committee of the 
Fig. 1  Pedigree drawing, clini-
cal findings, chromatograms 
and RT-PCR expression results 
for ATF6. a Pedigree drawing 
of MA28 family with autosomal 
recessive ACHM. Genotypes 
for the ATF6 c.355_356dupG 
variant are shown below each 
symbol of corresponding family 
members with available DNA 
samples. b Fundoscopy images 
and ERG data for affected 
proband III-1 (arrow in panel 
a) which shows bilateral loss 
of the foveal reflex and reduced 
cone response, respectively. 
Other retinal features are 
normal, including a pale-
centered optic disc with clear 
borders, 0.3–0.4 cup-to-disc 
ratio, and no arteriovenous 
nicking, hemorrhages, emboli 
or infarcts. c Chromatograms 
of family members who are 
homozygous, heterozygous and 
wild-type for the ATF6 variant. 
d RT-PCR results showed the 
presence of multiple ATF6 
isoforms in human eye and 
retinal pigment epithelium cells. 
I NM_007348.3 exons 1–16, 
2028 bp; II NM_007348.3 
exons 15–16, 265 bp; III 
AB208929 exon 14, 190 bp. 
Table S1 has additional details 
on isoforms and exons tested. 
GAPDH (143 bp) was used as 
internal control. Lanes: 1 100-
bp leader; 2, 5, 8 whole eye; 3, 
6, 9 retinal pigment epithelium; 
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University of Maryland, School of Medicine. C57BL/6 
mouse retinae were fixed in 4 % paraformaldehyde for 
30 min, washed in PBS, and homogenized and sonicated 
in ice-cold RIPA lysis buffer (Teknova R3792, Hollister, 
CA, USA) supplemented with protease inhibitor cocktail 
(Sigma-Aldrich P8340, St. Louis, MO, USA). Proteins 
were extracted and denatured by boiling at 95 °C for 5 min 
in SDS-PAGE sample buffer (0.125 M Tris–HCl, 20 % 
glycerol, 4 % SDS, 0.005 % bromophenol blue). A 50-μg 
protein sample was separated on a 4–20 % gradient Tris–
glycine gel (Novex, San Diego, CA, USA) and transferred 
to nitrocellulose membrane, blocked overnight at 4 °C with 
5 % dry milk in TBST (10 mM Tris–HCl pH 7.5, 150 mM 
NaCl, 0.05 % Tween 20), and stained with anti-ATF6 anti-
bodies (1:500 in blocking solution) for 1 h at room temper-
ature. After three washes, the membranes were incubated 
in a 1:1500 dilution of horseradish peroxidase-conjugated 
anti-rabbit secondary antibody (GE Healthcare) for 1 h at 
room temperature and developed using the ECL Plus West-
ern Blotting Detection system (Amersham Pharmacia Bio-
tech, Arlington Heights, IL, USA).
We also performed western blot analysis to study the 
steady state level of wild-type and mutant ATF6 proteins in 
transfected COS-7 cells. After 24 h of transfection, COS-7 
cells were collected and mixed with 2× sample loading 
buffer with reducing agent and processed for western blot 
analysis as described above.
Immunostaining, expression plasmid and localization 
assay
Cryo-preserved retinal sections from adult CD1 mice were 
rehydrated in PBS with 0.1 % Triton X-100 for 20 min. 
After blocking in 10 % Normal Goat Serum (NGS) for 
45 min at room temperature, sections were incubated with 
various concentrations of anti-ATF6 antibodies (abcam, 
Cambridge, MA, USA) in a dark humid chamber for 3 h, 
followed by washing in 1X PBS and conjugation with 
Alexa 488 secondary antibodies (Life Technologies, Carls-
bad, CA, USA). For nuclear DNA, we used 4′6-diamidino-
2-phenylindole (DAPI; 2 µg/ml). Actin was decorated with 
either rhodamine phalloidin (1:500) or Alexa 647-phalloi-
din (1:100). Sections were mounted with ProLong Gold 
antifade reagent (Molecular Probes, Life Technologies) and 
imaged using LSM510 (Zeiss, Pleasanton, CA, USA).
Human full-length (Accession no. NM_007348) ATF6 
flag-tagged and eGFP-tagged cDNA constructs were pur-
chased from GeneCopoeia (Rockville, MD). To insert the 
c.355_356dupG mutation, we performed site-directed 
mutagenesis on the construct using the QuikChange Light-
ening Kit (Agilent Technologies, Santa Clara, CA). To 
study expression and targeting, we transfected COS-7 cells, 
grown in DMEM that was supplemented with 10 % FBS, 
with flag-tagged wild-type and mutant ATF6 constructs. 
Transfected cells were maintained at 37 °C in 5 % CO2 for 
24 h. After incubation, transfected cells were fixed with 
4 % paraformaldehyde (EMS) in PBS for 30 min, permea-
bilized for 15 min in 0.2 % Triton X-100 and nonspecific 
binding sites were blocked by incubation in 2 % BSA and 
5 % normal goat serum in PBS for 30 min. COS-7 cells 
were incubated for 2 h at room temperature with anti-flag 
(1:500) and primary antibodies for Calregulin (1:500) as 
endoplasmic reticulum (ER) marker, followed by incu-
bation with Alexa Fluor 488 goat anti-mouse and Alexa 
Fluor 546 goat anti-rabbit secondary antibodies (Molecular 
Probes) for 45 min at room temperature. Rhodamine phal-
loidin was used to label actin cytoskeleton, while nuclei 
were decorated with DAPI. Samples were washed in PBS, 
mounted using ProLong Gold Antifade reagent (Molecular 
Probes), and imaged with the use of a LSM510 coreduo 
confocal microscope equipped with a Zeiss 63X objective 
(Zeiss Microimaging).
Antibody validation
To validate anti-ATF6 antibody (ab37149; abcam, Cam-
bridge, MA, USA), we performed a colocalization assay 
using flag-tagged ATF6-transfected COS-7 cells. The cells 
were grown on coverslips in Dulbecco’s modified Eagle’s 
medium (Invitrogen) supplemented with 10 % fetal bovine 
serum and then transfected with Lipofectamine reagent 
(Invitrogen). After incubation at 37 °C with 5 % CO2 for 
24 h, transfected cells were fixed with 4 % paraformal-
dehyde (EMS) in PBS for 30 min, permeabilized for 15 
min in 0.2 % Triton X-100 and nonspecific binding sites 
were blocked by incubation in 2 % BSA and 5 % normal 
goat serum in PBS for 30 min. Primary ATF6 and anti-flag 
antibodies were diluted in blocking solution to a final con-
centration of ~0.5 μg per ml. COS-7 cells were incubated 
for 2 h at room temperature with ATF6 and anti-flag anti-
bodies, followed by incubation with Alexa Fluor 546 goat 
anti-rabbit and Alexa Fluor 488 goat anti-mouse secondary 
antibodies (Molecular Probes) for 45 min at room tempera-
ture. Rhodamine phalloidin labeled the actin cytoskeleton 
and DAPI was used to stain nuclei. Samples were washed 
in PBS, mounted using ProLong Gold Antifade reagent 
(Molecular Probes), and imaged with the use of a LSM510 
coreduo confocal microscope.
Results
The four affected individuals (III-1, III-4, III-5, IV-1; 
Fig. 1a) of family MA28 presented with severe photopho-
bia, nystagmus and absence of color discrimination from 
early childhood. They have normal night vision, but in 
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daylight they experience extreme discomfort and exhibit 
extensive blinking. Complete physical examination and 
standard blood tests (e.g., blood cell counts, lipid profile, 
liver function tests, glucose, creatinine, among others) 
of all four affected individuals ruled out the presence of 
additional comorbidities (i.e., neurologic, otolaryngologic, 
hematologic, cardiovascular, respiratory, gastrointestinal, 
endocrine, urinary) and substantiated the presence of iso-
lated achromatopsia. The visual acuity measurements of the 
affected individuals range from 0.08 to 0.2. The Ishihara 
24-plate color test revealed severe defects in all affected 
individuals. Fundus examination of the proband III-1, at the 
age of 16 years, was normal except for loss of the foveal 
reflex (Fig. 1b). The ffERG of the same individual was 
typical of ACHM, i.e., (1) normal amplitude and latency of 
scotopic or rod response in dark-adapted phase at ≤30 Hz 
but subnormal rod response at 120 Hz, (2) absent photopic 
flicker response with loss of regular sinusoidal waveforms, 
and (3) normal latency but severely diminished amplitude 
of photopic or single cone flash response (Fig. 1b, S1). 
Additionally, oscillatory potentials were demonstrated dur-
ing scotopic responses at 30 Hz (Fig. 1b, S1), presumably 
indicating amacrine cell function during the rod response.
Homozygosity mapping using genome-wide genotypes 
from 11 family members indicated a 15.12-Mb region of 
homozygosity on chromosome 1q23.1–q24.3 (Fig. S2a). 
Linkage analysis yielded a maximum two-point LOD 
score of 3.1 (θ = 0) at rs6700867 (chr1:162.31 Mb; NCBI 
Build hg19). A statistically significant maximum mul-
tipoint LOD score of 3.6 was obtained at several mark-
ers from rs1538971 (chr1:161.68 Mb) to rs17350579 
(chr1:172.07 Mb). Both the minimum critical region 
identified by linkage analysis and the homozygous region 
were flanked by markers rs2758684 (chr1:157.54 Mb) 
and rs859652 (chr1:172.65 Mb) and include 15.12 Mb of 
sequence (Fig. S2b).
A DNA sample from the proband III-1 (Fig. 1a) under-
went exome sequencing. Within the homozygous region 
on chromosome 1q23.1–q24.3, from the exome sequence 
data there are 14 homozygous variants with zero MAF 
in the ExAC database. Of the 14 rare variants, 13 vari-
ants were intergenic or intronic and occurred in dbSNP, 
and are unlikely to be disease-causal. On the other hand, 
a duplication variant c.355_356dupG (p.Glu119Glyfs*8) 
within ATF6 (NM_007348.3) was absent in both dbSNP 
and ~120,000 ExAC alleles. Additionally, the variant was 
not identified in 470 ethnically matched control chromo-
somes or in exome sequence data from 130 unrelated Paki-
stani individuals with non-ophthalmologic traits. Sanger 
sequencing of DNA samples from the remaining mem-
bers of family MA28 confirmed co-segregation of the 
c.355_356dupG variant with ACHM (Fig. 1a, c). Two-point 
linkage analysis using genotypes for the c.355_356dupG 
variant yielded a statistically significant LOD score of 3.6 
(θ = 0).
The duplication of guanosine within exon 5 of ATF6 is 
predicted to alter the reading frame (Fig. S2c), thus result-
ing in the substitution of glutamic acid at position 119 with 
glycine followed by a frameshift. The variant introduces a 
premature nonsense codon before the amino acids encoding 
the basic region leucine zipper (BRLZ) and transmembrane 
(TM) domains (Fig. S3). Multiple sequence alignment of 
human ATF6 and related sequences from 96 species indi-
cated that several amino acid residues within the BRLZ 
domain are highly conserved or identical across species 
(Fig. S3a). These residues are also identical or highly con-
served in various human transcription factors, support-
ing the important role of the BRLZ domain in target gene 
activation (Fig. S3b). Molecular modeling at ≥90 % confi-
dence revealed that wild-type ATF6 is identical in sequence 
with other transcription factors by 45 % at maximum, but 
the sequence identity is limited to the BRLZ domain (Fig. 
S3c–d). Comparison of wild-type and mutant models for 
ATF6 predicts removal of ordered structure particularly of 
the BRLZ and TM domains (Fig. S3d).
There are three alternatively spliced isoforms of human 
ATF6 (Fig. 1d, S2c). Isoform AK290498 has 16 exons and 
encodes a 670-amino acid protein. Exon 16 is alternatively 
spliced in isoform AF005887 at the 3′UTR but has the 
same coding region as in isoform A. Isoform AB208929 
has 14 coding exons and encodes a 577-amino acid protein 
(Table S1). RT-PCR performed on commercially obtained 
RNA samples showed expression of all three ATF6 iso-
forms in human eye, particularly in retinal pigment epithe-
lium cells (Fig. 1d). All three ATF6 isoforms include exons 
1–5 in sequence, thus the duplication variant is predicted to 
affect all three isoforms in the same manner (Fig. S2c).
The occurrence of multiple isoforms and ATF6 multim-
ers in the eye is further confirmed by western blot analysis 
using anti-ATF6 antibodies on protein extract from adult 
C57BL/6J mouse retina (Fig. S3e). The anti-ATF6 antibod-
ies were validated in heterologous cells. Immunofluores-
cent staining with anti-ATF6 antibodies overlapped with 
the signal produced by tagged ATF6 expressed in COS-7 
cells (Fig. S4), which confirm the specificity of the anti-
body for ATF6. To explore the precise cellular localization 
in the eye, CD1 mouse retinae were examined for immu-
noreactivity with anti-ATF6 antibodies (Fig. 2, S5). ATF6 
immunoreactivity is most prominent in the retinal ganglion 
cells. Staining of ATF6 was also observed in the retinal pig-
ment epithelium, outer and inner segments of photorecep-
tor cells, inner and outer plexiform layers, as well as in the 
inner nuclear layer of neuronal retina (Fig. 2, S5).
ATF6 encodes a transcription factor that is initially syn-
thesized as an ER-embedded transmembrane protein. To 
determine the effect of the ATF6 p.Glu119Glyfs*8 variant 
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on steady state levels and localization, COS-7 cells were 
co-transfected with GFP-tagged human ATF6 constructs. 
As expected, confocal imaging of the tagged wild-type 
ATF6 revealed expression throughout the cytoplasm and 
localization to ER (Fig. 3a). In contrast, mutant ATF6 
with the p.Glu119Glyfs*8 variant had significantly 
reduced localization in the cytoplasm and was mainly con-
fined to the nucleus (Fig. 3a). Western blot analysis and 
Fig. 2  Localization of ATF6 in 
wild-type mouse retina. Immu-
nostaining in CD1 mouse retina 
with antibodies for DAPI (blue), 
rhodamine phalloidin (red) 
for actin-based structures and 
ATF6 (green). ATF6 strongly 
localized to the retinal ganglion 
cells (RGC), and had moderate 
staining of the outer and inner 
segments of photoreceptor cells 
(PR) and the inner plexiform 
(IPL), inner nuclear (INL) and 
outer plexiform (OPL) layers. 
ATF6 is weakly localized to 
the outer nuclear layer (ONL) 
which contains photoreceptor 
cell bodies (color figure online)
Fig. 3  Expression of wild-
type and mutant ATF6 in 
transfected COS-7 cells. a 
Flag-tagged wild-type ATF6 
protein is expressed throughout 
the cytoplasm and localized in 
the endoplasmic reticulum. In 
contrast, the p.Glu119Glyfs*8 
variant affected the stabil-
ity, targeting and localization 
of ATF6, with expression 
confined to the nucleus and 
significantly reduced cytoplas-
mic localization. Scale bars 
10 μm. b COS-7 cells were 
transiently transfected with the 
same quantity of wild-type or 
mutant ATF6 constructs. Protein 
extracts from the cell lysates 
were analyzed by western blot 
using an anti-ATF6 antibody. 
Flag-tagged wild-type ATF6 
protein is demonstrated at the 
expected size ~64 kDa and with 
dimer formation. In contrast, 
mutant ATF6 had reduced pro-
tein size. GAPDH antibody was 
used as loading control. Quan-
tification of the steady-state 
expression did not reveal any 
significant difference between 
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quantification, after normalization against the GAPDH 
expression level, revealed no significant difference in the 
steady state level of the p.Glu119Glyfs*8 mutant protein 
compared with wild-type ATF6 protein (Fig. 3b). Thus, in 
vitro, the p.Glu119Glyfs*8 variant affects the targeting and 
localization of ATF6.
Discussion
In this study, we identified a rare variant in ATF6 that seg-
regates with the ACHM phenotype. ATF6 lies within an 
autosomal recessive cone–rod dystrophy (CORD8) locus 
that was previously mapped in another Pakistani family 
to an 11.53-cM region on chromosome 1q12–q24 (Khaliq 
et al. 2000; Ismail et al. 2006). The affected individuals of 
the CORD8 family also presented with color vision loss, 
severe photophobia and progressive deterioration of vision 
since childhood. While the affected members of the CORD8 
family had night blindness (Khaliq et al. 2000), the affected 
individuals from our ACHM family had normal night vision. 
Mutations in four previously identified ACHM genes namely 
CNGA3, CNGB3, PDE6C and PDE6H can cause both 
ACHM and CORD (Huang et al. 2013; Li et al. 2014b). 
However, negative results from Sanger sequencing of all 
exons of ATF6 using DNA samples of two affected individ-
uals from the CORD8 family ruled out the involvement of 
ATF6 in the etiology of CORD. It is possible that another 
gene within chromosome 1q is responsible for CORD. On 
the other hand, genome-wide mapping and exome sequenc-
ing provided strong evidence that the ATF6 c.355_356dupG 
(p.Glu119Glyfs*8) variant causes ACHM in family MA28.
Although ATF6 is ubiquitously expressed, atf6−/− 
zebrafish and both Atf6α−/− and Atf6β−/− mice do not have 
obvious developmental abnormalities, while double knock-
out mice for Atf6α−/−;Atf6β−/− were embryonic lethal (Wu 
et al. 2007; Yamamoto et al. 2007; Cinaroglu et al. 2011). 
There is also evidence that Atf6α-null mice subjected to 
high-fat diet develop glucose intolerance and after ischemic 
stroke have greater size of brain infarcts, both of which 
are explained by conditions of ER stress (Usui et al. 2012; 
Yoshikawa et al. 2015). In family MA28, there is no evi-
dence of morphologic, cardiovascular, endocrine, or neu-
rologic disease except for ACHM from early childhood. 
RT-PCR showed expression of all ATF6 isoforms in retina 
(Fig. 1d), which are predicted to be equally affected by the 
ATF6 c.355_356dupG variant. In humans, truncating ATF6 
variants that affect all isoforms may result in specific phe-
notypes brought about by ER stress, which in the case of 
the retina may be due to light exposure or inherited defi-
ciencies (Thapa et al. 2012).
In general, cells respond to ER stress by activating the 
unfolded protein response (UPR) to facilitate ER protein 
folding and reduce misfolded protein levels (Chiang et al. 
2012). In retinas exposed to ER stress due to excessive light 
injury, ATF6 mediates early UPR which serves to suppress 
ER stress and restore homeostasis (Nakanishi et al. 2013). 
ATF6 also activates IRE1 which mediates late UPR, during 
which ATF6 activation is decreased and severe or prolonged 
stress can result in apoptotic cell death (Lin et al. 2007; 
Nakanishi et al. 2013). ER stress-associated apoptotic cell 
death has been implicated as a common pathway for retinal 
degenerative disease, including ACHM due to gene defects 
in photoreceptor cyclic nucleotide-gated channels CNGA3 
and CNGB3 (Thapa et al. 2012). Rod–cone photorecep-
tor dysfunction has been clearly demonstrated in the pres-
ence of mutation in other ACHM genes (Kohl et al. 2000; 
Thiadens et al. 2010; Aboshiha et al. 2014). Expression of 
previously identified ACHM genes has been equally distrib-
uted throughout the retina. Likewise, ATF6 has ubiquitous 
retinal expression with strongest localization in retinal gan-
glion cells and moderate staining at the retinal pigment epi-
thelium, photoreceptor outer and inner segments, outer and 
inner plexiform and inner nuclear layers (Fig. 2, S5).
While all these cell layers that express ATF6 are widely 
known to be involved in color vision, absence of photopic 
a-waves in the ffERG of the ACHM proband from fam-
ily MA28 supports functional loss of cone photoreceptors 
due to the ATF6 duplication variant (Fig. 1b). The role of 
the ATF6 pathway in retinal ER stress response was pre-
viously described within photoreceptor cells (Yang et al. 
2007, 2008; Saito 2014). In photoreceptors, ATF6 mRNA 
and protein expression is upregulated after light or drug 
exposure (Chiang et al. 2012; Li et al. 2014a). On the other 
hand, photopic b-wave diminution in the ffERG can be 
due to the absence of cone photoreceptor response and/or 
Müller and on-bipolar cell dysfunction at the inner retinal 
layers. Several studies have demonstrated the ER stress 
response through ATF6 within the inner retina. In particu-
lar, ER stress within normal and disease contexts (e.g., 
drug exposure, genetic loss of ER transmembrane protein, 
diabetic retinopathy) resulted in increased ATF6 expres-
sion in Müller glial and retinal ganglion cells (Yoshikawa 
et al. 2011; Wu et al. 2012; Miyagi et al. 2013; Ha et al. 
2014; Zode et al. 2014). Although ffERG does not capture 
ganglion cell function, it is interesting to note that retinal 
ganglion cells primarily synapse with bipolar cells within 
the cone system. Retinal ganglion cells have been identified 
as the retinal cells most affected by ER stress due to dia-
betes (Yang et al. 2013) and glaucoma (Zode et al. 2014), 
and color vision defects have been documented in both 
acquired disease states (Lin and Yang 2010; Shoji et al. 
2011). The unique retinal staining pattern of ATF6 with 
strongest localization to ganglion cells might imply that 
the ATF6 pathway within the retinal ganglion cells plays a 
major role in color vision.
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In response to ER stress, ATF6 undergoes proteolysis to 
release its BRLZ domain, which binds to the ER stress response 
element to activate expression of downstream target genes 
within the nucleus (Haze et al. 1999). The interplay between 
transcription factors and target genes involved in the ER stress 
pathway is thought to allow fine-tuning of the UPR response 
that is cell or tissue specific (Saito 2014). Although Mutation-
Taster (Schwarz et al. 2014) predicts the ATF6 frameshift vari-
ant to initiate nonsense-mediated decay, immunolocalization 
studies in COS-7 cells overexpressing the mutant ATF6 cDNA 
construct revealed the production of a smaller protein that is 
predominantly mislocalized to the nucleus (Fig. 3). Reduced 
cytoplasmic expression of truncated protein is to be expected 
given the loss of the TM domain that anchors ATF6 to the ER 
(Haze et al. 1999). While ATF6 is required to translocate to the 
nucleus to activate ER stress genes, the lack of a functional 
BRLZ domain in the truncated ATF6 protein should preclude 
DNA binding and UPR activation. Our experiments therefore 
predict that in vivo ATF6 protein with the frameshift variant is 
not reduced in overall amount of expression but is truncated, 
mislocalized and non-functional.
In conclusion, we identified a variant in ATF6 as the 
underlying cause of autosomal recessive achromatopsia. This 
finding lends further support to the importance of the ATF6 
pathway in retinal function. ATF6 is localized throughout the 
retina, with strongest staining within retinal ganglion cells. 
Taken together, our findings imply that the ATF6 pathway is 
essential in color vision not just within photoreceptors but 
also within the inner retina, and is a potential target for treat-
ment for either inherited or acquired retinal diseases.
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